semaglutideglp1telogen effluvium
Semaglutide and Hair Loss: What 18 Months of Real-World Data Shows
GLP-1 receptor agonists like semaglutide and tirzepatide produce dramatic metabolic shifts and rapid weight loss. Real-world pharmacovigilance and trial data reveal a consistent 3% to 6% incidence of acute telogen effluvium triggered by metabolic shock and nutrient partitioning rather than direct follicular toxicity.
Nov 2, 2026·14 days ago